Condensed Consolidated Statements of Stockholders' Equity - USD ($) shares in Thousands, $ in Thousands	Common stock	Additional Paid-in Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit	Total
Balance at Dec. 31, 2022	$ 11	$ 2,664,730	$ (16,362)	$ (1,942,635)	$ 705,744
Balance (in shares) at Dec. 31, 2022	111,255
Issuance of common stock upon exercise of stock options		2,301			2,301
Issuance of common stock upon exercise of stock options (in shares)	169
Issuance of common stock for IPR&D acquisition		14,435			14,435
Issuance of common stock for IPR&D acquisition (in shares)	336
Vesting of restricted stock units (in shares)	1,250
Stock based compensation		40,695			40,695
Issuance of common stock for bonus		19,771			19,771
Issuance of common stock for bonus (in shares)	349
Unrealized gain on available-for sale securities			4,564		4,564
Net loss				(136,937)	(136,937)
Balance at Mar. 31, 2023	$ 11	2,741,932	(11,798)	(2,079,572)	650,573
Balance (in shares) at Mar. 31, 2023	113,359
Balance at Dec. 31, 2023	$ 11	3,145,837	(3,085)	(2,377,436)	$ 765,327
Balance (in shares) at Dec. 31, 2023	119,581				119,581
Issuance of common stock upon exercise of stock options		6,466			$ 6,466
Issuance of common stock upon exercise of stock options (in shares)	792
Vesting of restricted stock units	$ 1				1
Vesting of restricted stock units (in shares)	1,591
Stock based compensation		64,952			64,952
Issuance of common stock for bonus		24,071			24,071
Issuance of common stock for bonus (in shares)	270
Unrealized gain on available-for sale securities			893		893
Net loss				(67,599)	(67,599)
Balance at Mar. 31, 2024	$ 12	$ 3,241,326	$ (2,192)	$ (2,445,035)	$ 794,111
Balance (in shares) at Mar. 31, 2024	122,234				122,234